November 13, 2019

MabPlex Congratulates Encure Biopharma with FDA IND Clearance of YH001 for the Treatment of a Broad Range of Cancers

MabPlex International Ltd. confirms securing United States Food and Drug Administration (FDA) Investigational New Drug (IND) clearance for Encure Biopharma Co., Ltd.’s (Beijing) YH001 project. Following […]
Do you like it?0
Read more

CONNECT WITH MABPLEX        

MABPLEX
SOCIAL HUB

X
INFORMATION